1. Home
  2. NIC vs ARQT Comparison

NIC vs ARQT Comparison

Compare NIC & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NIC
  • ARQT
  • Stock Information
  • Founded
  • NIC 2000
  • ARQT 2016
  • Country
  • NIC United States
  • ARQT United States
  • Employees
  • NIC N/A
  • ARQT N/A
  • Industry
  • NIC Major Banks
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NIC Finance
  • ARQT Health Care
  • Exchange
  • NIC Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • NIC 1.4B
  • ARQT 1.1B
  • IPO Year
  • NIC N/A
  • ARQT 2020
  • Fundamental
  • Price
  • NIC $111.54
  • ARQT $9.26
  • Analyst Decision
  • NIC Hold
  • ARQT Strong Buy
  • Analyst Count
  • NIC 5
  • ARQT 5
  • Target Price
  • NIC $101.60
  • ARQT $14.40
  • AVG Volume (30 Days)
  • NIC 69.7K
  • ARQT 2.4M
  • Earning Date
  • NIC 10-15-2024
  • ARQT 11-06-2024
  • Dividend Yield
  • NIC 1.00%
  • ARQT N/A
  • EPS Growth
  • NIC 102.58
  • ARQT N/A
  • EPS
  • NIC 7.86
  • ARQT N/A
  • Revenue
  • NIC $342,790,000.00
  • ARQT $138,708,000.00
  • Revenue This Year
  • NIC N/A
  • ARQT $208.32
  • Revenue Next Year
  • NIC $4.63
  • ARQT $48.56
  • P/E Ratio
  • NIC $14.22
  • ARQT N/A
  • Revenue Growth
  • NIC 28.93
  • ARQT 182.84
  • 52 Week Low
  • NIC $72.70
  • ARQT $1.76
  • 52 Week High
  • NIC $116.17
  • ARQT $13.17
  • Technical
  • Relative Strength Index (RSI)
  • NIC 61.73
  • ARQT 46.45
  • Support Level
  • NIC $99.64
  • ARQT $8.29
  • Resistance Level
  • NIC $116.17
  • ARQT $10.76
  • Average True Range (ATR)
  • NIC 3.10
  • ARQT 0.66
  • MACD
  • NIC 0.48
  • ARQT 0.09
  • Stochastic Oscillator
  • NIC 71.99
  • ARQT 32.51

About NIC Nicolet Bankshares Inc.

Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: